Biomedicines (Jun 2024)

Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications

  • Hiromichi Sato,
  • Sikun Meng,
  • Tomoaki Hara,
  • Yoshiko Tsuji,
  • Yasuko Arao,
  • Kazuki Sasaki,
  • Shogo Kobayashi,
  • Eric di Luccio,
  • Takaaki Hirotsu,
  • Taroh Satoh,
  • Yuichiro Doki,
  • Hidetoshi Eguchi,
  • Hideshi Ishii

DOI
https://doi.org/10.3390/biomedicines12061342
Journal volume & issue
Vol. 12, no. 6
p. 1342

Abstract

Read online

Gastrointestinal cancers, which include a variety of esophageal and colorectal malignancies, present a global health challenge and require effective treatment strategies. In the evolving field of cancer immunotherapy, tissue-resident memory T cells (Trm cells) have emerged as important players in the immune response within nonlymphoid tissues. In this review, we summarize the characteristics and functions of Trm cells and discuss their profound implications for patient outcomes in gastrointestinal cancers. Positioned strategically in peripheral tissues, Trm cells have functions beyond immune surveillance, affecting tumor progression, prognosis, and response to immunotherapy. Studies indicate that Trm cells are prognostic markers and correlate positively with enhanced survival. Their presence in the tumor microenvironment has sparked interest in their therapeutic potential, particularly with respect to immune checkpoint inhibitors, which may improve cancer treatment. Understanding how Trm cells work will not only help to prevent cancer spread through effective treatment but will also contribute to disease prevention at early stages as well as vaccine development. The role of Trm cells goes beyond just cancer, and they have potential applications in infectious and autoimmune diseases. This review provides a thorough analysis of Trm cells in gastrointestinal cancers, which may lead to personalized and effective cancer therapies.

Keywords